Oritavancin
Indication
Management of patients with skin and soft tissue infections
Red
Brand:
Nice TA:
Commissioning responsibility:
CCG
PbR excluded:
No
BNF chapter:
Infection
Background
Recommendation: RED for the following indications:
Treatment of acute, complicated bacterial skin and skin structure infections (ABSSSI) in adults, with confirmed drug-resistant gram-positive infection, who are eligible for early discharge.
Use must be on the advice of local microbiologists and must be reserved for the treatment of patients who would otherwise be required to have a prolonged inpatient stay due to unsuitability for OPAT
Recommendation
LSCMMG Recommendation:
Red
Reason for decision:
Specialist medicine
Supporting documents: